Therapy Analysis & Statistics, January 2015 (p4)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

91-120 of about 2 200 reports

Purchase Reports From Reputable Market Research Publishers

Regulus Therapeutics Inc. (RGLS) - Financial and Strategic SWOT Analysis Review

Regulus Therapeutics Inc. (RGLS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Regulus Therapeutics Inc. (Regulus Therapeutics) is a biopharmaceutical company. The company discovers, develops and commercializes microRNA based therapeutics. It develops single stranded oligonucleotides, ...

  • Industries : Therapy
  • Countries : United States
Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review

Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnology company. The company develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein ...

  • Industries : Therapy
  • Countries : United States
Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review

Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Onconova Therapeutics, Inc. (Onconova) is a biopharmaceutical company. The company discovers and develops novel small molecule drug candidates to treat cancer. It develops targeted anti-cance ...

  • Industries : Therapy
  • Countries : United States
Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review

Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Stemline Therapeutics, Inc. (Stemline) is a clinical stage biopharmaceutical company. The company develops oncology compounds, which targets both cancer stem cells (CSC's) and the tumor bulk. Its ...

  • Industries : Therapy
  • Countries : United States
Capstone Therapeutics Corp. (CAPS) - Financial and Strategic SWOT Analysis Review

Capstone Therapeutics Corp. (CAPS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Capstone Therapeutics Corp. (Capstone) is a biotechnology company. The company develops novel peptides and other molecules to support patients with under-served medical conditions. It develops ...

  • Industries : Therapy
  • Countries : United States
Sevion Therapeutics, Inc. (SVON) - Financial and Strategic SWOT Analysis Review

Sevion Therapeutics, Inc. (SVON) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Sevion Therapeutics, Inc.(Sevion) is a cancer therapeutic company. The company provides eukaryotic translation initiation Factor 5A (eIF5A) technology to regulate cell death and survival. It offers ...

  • Industries : Therapy
  • Countries : United States
Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Tesaro, Inc. (Tesaro) is an oncology-focused biopharmaceutical company. It focuses on acquiring, in-licensing, developing and commercializing oncology therapeutics and supportive care products. ...

  • Industries : Therapy
  • Countries : United States
Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review

Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Aratana Therapeutics, Inc. (Aratana) is a pet therapeutics company. It undertakes the acquisition, development and commercialization of biopharmaceutical products to address the unmet medical needs ...

  • Industries : Therapy
  • Countries : United States
Merger & Acquisition in Medical Equipment Industry: Opexa Therapeutics, Inc. (OPXA)

Merger & Acquisition in Medical Equipment Industry: Opexa Therapeutics, Inc. (OPXA)

  • $ 250
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Ocata Therapeutics, Inc. (OCAT) - Medical Equipment - Deals and Alliances Profile

Ocata Therapeutics, Inc. (OCAT) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary Ocata Therapeutics, Inc. (Ocata) is formerly know as Advanced Cell Technology, Inc. is a biotechnology company, specializes in regenerative medicine. The company participates in the development ...

  • Industries : Therapy
  • Countries : United States
Guided Therapeutics, Inc. (GTHP) - Medical Equipment - Deals and Alliances Profile

Guided Therapeutics, Inc. (GTHP) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary Guided Therapeutics, Inc. (GTI) is a medical technology company. The company offers products for the non-invasive cervical cancer detection markets. It develops technology to painlessly detect ...

  • Industries : Therapy
  • Countries : Mexico
Regulus Therapeutics Inc. (RGLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Regulus Therapeutics Inc. (RGLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by Global Data

Summary Regulus Therapeutics Inc. (Regulus Therapeutics) is a biopharmaceutical company. The company discovers, develops and commercializes microRNA based therapeutics. It develops single stranded oligonucleotides, ...

  • Industries : Therapy
  • Countries : United States
The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by Global Data

Summary The Scripps Research Institute (TSRI) is a research and educational organization. The institute conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune ...

  • Industries : Therapy
  • Countries : United States
The University of Utah - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The University of Utah - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by Global Data

Summary The University of Utah is a research university. It offers undergraduate and postgraduate degrees through its colleges and schools and nearly 100 departments. It offers educational programs in ...

  • Industries : Therapy
  • Countries : United States
NicOx S.A. (COX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NicOx S.A. (COX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by Global Data

Summary NicOx S.A. (NicOx) is a pharmaceutical company. It focuses on the development of ophthalmic portfolio of therapies and diagnostic tools. The company's products portfolio includes ophthalmic products ...

  • Industries : Therapy
e-Therapeutics plc (Symbol:ETX) SWOT Analysis, Strategy, Revenues and Profits

e-Therapeutics plc (Symbol:ETX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Acorda Therapeutics, Inc. (Symbol:ACOR) SWOT Analysis, Strategy, Revenues and Profits

Acorda Therapeutics, Inc. (Symbol:ACOR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Silence Therapeutics Plc

Silence Therapeutics Plc

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Silence Therapeutics Plc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Imarx Therapeutics, Incorporation.

Imarx Therapeutics, Incorporation.

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Imarx Therapeutics, Incorporation. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Sorrento Therapeutics Incorporation

Sorrento Therapeutics Incorporation

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Sorrento Therapeutics Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
United Therapeutics Corporation, Wright Investors' Service

United Therapeutics Corporation, Wright Investors' Service

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Orexigen Therapeutics Inc

Orexigen Therapeutics Inc

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Orexigen Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Capricor Therapeutics Inc

Capricor Therapeutics Inc

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Capricor Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Celldex Therapeutics, Incorporation

Celldex Therapeutics, Incorporation

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Celldex Therapeutics, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Addex Therapeutics

Addex Therapeutics

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Addex Therapeutics compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Therapy
Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc.

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Manhattan Scientifics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Acorda Therapeutics, Inc., Wright Investors' Service

Acorda Therapeutics, Inc., Wright Investors' Service

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Acorda Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
  • Countries : United States
Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc.

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Osiris Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
D.Western Therapeutics Institute Incorporation

D.Western Therapeutics Institute Incorporation

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for D.Western Therapeutics Institute Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Therapy
Pernix Therapeutics Holdings Incorporated

Pernix Therapeutics Holdings Incorporated

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Pernix Therapeutics Holdings Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Therapy
About 300 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • January 2015
    3 pages
  • Therapy  

    Radiation Thera...  

    Chemotherapy  

  • United States  

View report >

Therapy Markets In The Us

September 2014

60 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.